Thiotepa

Spécifications

52-24-4Numéro CAS

200-135-7Numéro CE

tris(aziridin-1-yl)-sulfanylidene-lambda5-phosphaneNom IUPAC

C6H12N3PSFormule chimique

189.22 g/molMasse molaire

thiotepa; 52-24-4; THIO-TEPA; Triethylenethiophosphoramide; Thiophosphamide; Thioplex; Tespamin; Tespamine; Thiofozil; Girostan; Tifosyl; Stepa; Oncotiotepa; TESPA; Thiotef; tepadina; Ledertepa; Tris(1-aziridinyl)phosphine sulfide; Thiotriethylenephosphoramide; NSC-6396; TIO TEF; Tepylute; Tiotepa; Thiophosphamidum; Triethylene thiophosphoramide; N,N',N''-Triethylenethiophosphoramide; Triaziridinylphosphine sulfide; Triethylenethiophosphorotriamide; Tris(ethylenimino)thiophosphate; Thiotepum; Phosphorothioic acid triethylenetriamide; Tri(ethyleneimino)thiophosphoramide; NSC 6396; DTXSID0021339; Tris(1-aziridinyl)phosphine sulphide; N,N',N''-Triethylenethiophosphamide; NSC6396; 1,1',1''-Phosphinothioylidynetrisaziridine; N,N',N''-Triethylenephosphorothioic triamide; N,N',N''-Tri-1,2-ethanediylthiophosphoramide; 905Z5W3GKH; AZIRIDINE,1,1',1''-PHOSPHINOTHIOYLIDYNETRIS-; WR 45312; DTXCID201339; tris(aziridin-1-yl)-lambda5-phosphanethione; tris(aziridin-1-yl)-sulfanylidenephosphorane; Thio Tepa; tris(aziridin-1-yl)-$l^(5)-phosphanethione; tris(aziridin-1-yl)-$l^{5}-phosphanethione; Thiofosfamide; AI3 24916; AI324916; RefChem:897941; L01AC01; N,N', N''-Triethylenethiophosphoramide; 1,1',1''-Phosphinothioyldynetrisaziridine; 1,1',1\"-phosphinothioylidynetrisaziridine; 200-135-7; TSPA; Tiofosfamid; Tri(aziridin-1-yl)phosphine sulfide; Oncotepa; Tiofosyl; Tiofozil; Oncothio-tepa; Tio-tef; Thio-Tep; Thio-tepa S; 1,1',1''-phosphorothioyltriaziridine; CBC 806495; Phosphine sulfide, tris(1-aziridinyl)-; NCI-C01649; SK 6882; Tris(aziridinyl)phosphine sulfide; Aziridine, 1,1',1''-phosphinothioylidynetris-; Tri-1-aziridinylphosphine sulfide; Tri(1-aziridinyl)phosphine sulfide; N,N',N''-Triethylenethiophosphortriamide; MFCD00145452; Thiophosphoramide, N,N',N''-tri-1,2-ethanediyl-; N,N',N''-Tri-1,2-ethanediylphosphorothioic triamide; MLS001333083; MLS003389372; Phosphorothioic triamide, N,N',N''-tri-1,2-ethanediyl-; AI 3-24916; Phosphorothioic triamide, N,N',N''-triethylene-; NCGC00095042-04; NCGC00095042-06; C6H12N3PS; Thiotepum [INN-Latin]; Tiotepa [INN-Spanish]; CAS-52-24-4; SMR000058542; CCRIS 586; HSDB 3258; AI3-24916; SR-05000001855; EINECS 200-135-7; BRN 0145978; UNII-905Z5W3GKH; WR-45312; thiotepa?; Thiotepa [USP:INN:BAN:JAN]; Tepadina (TN); Thioplex (TN); Rethio (TN); Thiotepa (Thioplex); Spectrum_001689; Thio-TEPA (Standard); THIOTEPA [HSDB]; THIOTEPA [IARC]; THIOTEPA [INN]; THIOTEPA [JAN]; Thiophosphoramide, N,N',N''-triethylene-; THIOTEPA [MI]; THIOTEPA [VANDF]; Spectrum2_001557; Spectrum3_001594; Spectrum4_000208; Spectrum5_001641; THIOTEPA [MART.]; tris(aziridin-1-yl)-thioxo-$l^{5}-phosphane; CHEMBL671; THIOTEPA [USP-RS]; THIOTEPA [WHO-DD]; Thioplex (TN) (Immunex); SCHEMBL4760; Thiotepa (JAN/USP/INN); THIOTEPA [EMA EPAR]; Thio-TEPA, 98%, solid; BSPBio_003188; KBioGR_000815; KBioSS_002169; 4-20-00-00052 (Beilstein Handbook Reference); MLS001333084; MLS002207150; MLS006009972; BIDD:GT0127; DivK1c_000817; SPECTRUM1503324; SPBio_001434; tris(aziridin-1-yl)-sulfanylidene-lambda5-phosphane; THIOTEPA [ORANGE BOOK]; CHEBI:9570; GTPL7622; orb1309233; THIOTEPA [USP MONOGRAPH]; HMS502I19; KBio1_000817; KBio2_002169; KBio2_004737; KBio2_007305; KBio3_002688; N,N''-Triethylenethiophosphamide; NINDS_000817; GLXC-06101; HMS1922A14; HMS2093E05; HMS2232P17; HMS3372D10; HMS3753E09; HMS5080I05; N,N''-Triethylenethiophosphoramide; Pharmakon1600-01503324; ALBB-034802; Tox21_111399; Tox21_400065; BDBM50418086; CCG-39776; EBC-06025; HY-17574R; MSK164080; NSC758455; s1775; AKOS005267118; CS-3119; DB04572; FT03758; NSC-758455; 1,1''-Phosphinothioylidynetrisaziridine; IDI1_000817; Thiophosphoramide,N',N'' -triethylene-; N,N',N'''-Triethylenethiophosphhoramide; NCGC00095042-01; NCGC00095042-02; NCGC00095042-03; NCGC00095042-05; NCGC00095042-07; NCGC00095042-08; NCGC00095042-09; NCGC00095042-14; PHOSPHOROTHIOIC TRI(ETHYLENEAMIDE); AS-16885; HY-17574; N,N''-Triethylenephosphorothioic triamide; NCI60_013117; 1,1',1''-Phosphorothioyltris(aziridine); SBI-0051814.P002; Aziridine,1',1''-phosphinothioylidynetris-; N,N''-Tri-1,2-ethanediylthiophosphoramide; Phosphorothioic triamide,N',N''-triethylene; Thiophosphoramide, N,N',N'' -triethylene-; NS00010011; WLN: T3NTJ APS&- AT3NTJ&- AT3NTJ; tris(aziridin-1-yl)-thioxo-lambda5-phosphane; 1-[Di(1-aziridinyl)phosphorothioyl]aziridine #; C07641; D00583; EN300-120883; Phosphorothioic triamide, N,N',N''-triethylene; Thiophosphoramide,N',N''-tri-1,2-ethanediyl-; AB00052346-06; AB00052346_07; N,N''-Tri-1,2-ethanediylphosphorothioic triamide; Q416507; SR-05000001855-1; SR-05000001855-5; 1,1',1''-PHOSPHINOTHIOYLIDYNETRIS(AZIRIDINE); BRD-K09631521-001-05-7; BRD-K09631521-001-09-9; BRD-K09631521-001-11-5; Phosphorothioic triamide,N',N''-tri-1,2-ethanediyl-; Z1201619320; Thiotepa, United States Pharmacopeia (USP) Reference Standard; 1631739-26-8Synonymes